TY - JOUR T1 - The 2023 EBMT report on hematopoietic cell transplantation and cellular therapies. Increased use of allogeneic HCT for myeloid malignancies and of CAR-T at the expense of autologous HCT JO - Bone Marrow Transplantation UR - https://eprints.whiterose.ac.uk/id/eprint/223626 PY - 2025/02/12 AU - Passweg JR AU - Baldomero H AU - Atlija M AU - Kleovoulou I AU - Witaszek A AU - Alexander T AU - Angelucci E AU - Averbuch D AU - Bazarbachi A AU - Ciceri F AU - Greco R et al ED - DO - DOI: 10.1038/s41409-025-02524-2 PB - Springer Science and Business Media LLC SP - 1 EP - 10 Y2 - 2025/04/09 ER -